367
Participants
Start Date
January 9, 2019
Primary Completion Date
August 23, 2024
Study Completion Date
May 28, 2025
osimertinib
osimertinib (80 mg oral OD).
savolitinib
savolitinib (300 mg oral OD or 300 mg oral BID or 600 mg oral OD)
placebo
placebo to osimertinib (oral OD)
Research Site, Taipei
Research Site, Hsinchu
Research Site, Taoyuan District
Research Site, Taichung
Research Site, København Ø
Research Site, Herlev
Research Site, Næstved
Research Site, Odense
Research Site, Vejle
Research Site, Aalborg
Research Site, Taipei
Research Site, Orbassano
Research Site, Goyang-si
Research Site, Brooklyn
Research Site, Seongnam-si
Research Site, Marseille
Research Site, Córdoba
Research Site, Pittsburgh
Research Site, Suwon
Research Site, Philadelphia
Research Site, Donostia / San Sebastian
Research Site, Washington D.C.
Research Site, Milan
Research Site, Milan
Research Site, Dijon
Research Site, Baltimore
Research Site, New Taipei City
Research Site, Madrid
Research Site, Madrid
Research Site, Málaga
Research Site, Rennes
Research Site, Padua
Research Site, Peschiera del Garda
Research Site, Taichung
Research Site, Parma
Research Site, Nantes
Research Site, Valencia
Research Site, Zaragoza
Research Site, Florence
Research Site, Rochester
Research Site, Tainan City
Research Site, Paris
Research Site, Paris
Research Site, Avellino
Research Site, Kaohsiung City
Research Site, Los Angeles
Research Site, La Jolla
Research Site, Sacramento
Research Site, Seattle
Research Site, Hà Nội
Research Site, New Delhi
Research Site, Bangalore
Research Site, Chennai
Research Site, Ho Chi Minh City
Research Site, Kolkata
Research Site, Santiago
Research Site, Santiago
Research Site, Santiago
Research Site, Boston
Research Site, Barretos
Research Site, Curitiba
Research Site, Goiânia
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, Salvador
Research Site, São José do Rio Preto
Research Site, São Paulo
Research Site, São Paulo
Research Site, Calgary
Research Site, Edmonton
Research Site, Newmarket
Research Site, North York
Research Site, Toronto
Research Site, Toronto
Research Site, Perugia
Research Site, Fukuoka
Research Site, Hiroshima
Research Site, Kanazawa
Research Site, Nagoya
Research Site, Niigata
Research Site, Sapporo
Research Site, Sayama
Research Site, Sunto-gun
Research Site, Wakayama
Research Site, Yokohama
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Lead Sponsor
Hutchison Medipharma Limited
INDUSTRY
AstraZeneca
INDUSTRY